TabletsTablets
Schedule H (Prescription Required)Antiviral FormulationsCode: 746

Valganciclovir Hydrochloride Tablets 450 mg

Generic Formulation:Valganciclovir Hydrochloride Tablets USP 450 mg
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹1740
Brand Estimate*
₹3658.07
Estimated Savings:₹1918.07 (52% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Valganciclovir is an orally bioavailable L-valyl ester prodrug of ganciclovir. After absorption, it undergoes rapid conversion by esterases to ganciclovir, which is phosphorylated by viral protein kinase pUL97 and cellular kinases into ganciclovir triphosphate, a potent inhibitor of cytomegalovirus (CMV) DNA polymerase. Indicated for the induction and maintenance treatment of CMV retinitis in immunocompromised patients (such as those with AIDS) and prevention of CMV disease in solid organ transplant recipients.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 746.Report inaccuracy

Usage Guidelines

Take strictly with food to maximize systemic absorption and therapeutic bioavailability. Swallow tablets whole; do not break, crush, or chew because ganciclovir has potential teratogenic and mutagenic properties. Follow exact dosing regimens calibrated by your specialist.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Diarrhea, pyrexia, nausea, headache, anemia, and neutropenia. Rare/Severe: Severe hematologic cytopenias (leukopenia, severe neutropenia, thrombocytopenia, pancytopenia), renal impairment, seizures, and male infertility/teratogenicity.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Black box safety warning: High risk of bone marrow suppression, teratogenesis, and reproductive toxicity. Strict contraceptive measures required during and after treatment. Regular complete blood counts (CBC) and serum creatinine monitoring are mandatory.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.